Published • loading... • Updated
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
- WuXi AppTec Co., Ltd., a global pharmaceutical CRDMO, announced its 2026 interim cash dividend distribution.
- The company increased its 2026 interim dividend payout to RMB 1.51 billion, up from RMB 1.03 billion in 2025.
- WuXi AppTec is expanding its global capacity and capabilities while focusing on returning value to shareholders.
- WuXi AppTec provides R&D and manufacturing services to support healthcare innovation in the pharmaceutical and life sciences industries.
Insights by Ground AI
35 Articles
35 Articles
The Courier-Tribune+33 Reposted by 33 other sources
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
SHANGHAI, Aug. 30, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026 interim cash dividend. Building on its inaugural interim dividend of…
Coverage Details
Total News Sources35
Leaning Left3Leaning Right6Center23Last UpdatedBias Distribution72% Center
Bias Distribution
- 72% of the sources are Center
72% Center
C 72%
R 19%
Factuality
To view factuality data please Upgrade to Premium
